Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from MicroPort CardioFlow Medtech Corp. ( (HK:2160) ).
MicroPort CardioFlow Medtech Corp. has announced its acquisition of the remaining 49% equity interest in MP CardioAdvent, making it a wholly-owned subsidiary. This move is part of a strategic effort to consolidate its holdings and strengthen its position in the cardiovascular device market. The acquisition is classified as a disclosable and connected transaction under Hong Kong’s Listing Rules, requiring approval from independent shareholders.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. operates in the medical technology industry, focusing on cardiovascular devices. The company is known for its innovative solutions in cardiac care and aims to enhance its market presence through strategic acquisitions.
Average Trading Volume: 5,248,636
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.03B
For a thorough assessment of 2160 stock, go to TipRanks’ Stock Analysis page.